Kwality Pharmaceuticals Q2 Results
- BSE: 539997
- NSE: KPL
- ISIN: INE552U01010
- Sector: Biotechnology & Drugs
BSE
3,449.00
-193.50 (-5.31%)
-193.50 (-5.31%)Volume2.82 K
Updated: Tue 15 Sep, 2026 | 15:29:59
NSE
3,475.40-167.90 (-4.61%)
-167.90 (-4.61%)Volume44.24 K
Updated: Tue 15 Sep, 2026 | 15:08:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Kwality Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 90.66 | 126.33 | -1.53% |
| Depreciation/ Amortization | 4.96 | 4.99 | 4.09% |
| Operating Income | 20.40 | 36.03 | 5.07% |
| Net Income | 14.12 | 25.62 | 18.37% |
| Other Operating Expenses Total | 17.76 | 19.16 | 3.77% |
| Net Income Before Taxes | 18.45 | 33.99 | 8.36% |
| Total Revenue | 111.05 | 162.35 | -0.38% |
| Selling/ General/ Admin Expenses Total | 13.31 | 14.74 | 9.53% |
| Diluted Normalized EPS | 13.60 | 24.69 | 18.36% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.